K Number
K160355
Device Name
CX20N(CX20PUX)
Manufacturer
Date Cleared
2016-04-07

(59 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The CX20N(CX20PUX) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners.
Device Description
CX20N(CX20PUX) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for color image display. The WIDE controller board is installed into the PACS workstation computer system to display PACS medical images.
More Information

Not Found

No
The description focuses on the monitor's display capabilities and connection to a PACS workstation, with no mention of AI or ML algorithms for image analysis or processing beyond basic display functions.

No
The device is described as an LCD monitor system used for displaying and viewing digital medical images, not for administering therapy or treating medical conditions.

No
The device is described as an LCD monitor system for displaying and viewing digital medical images, not for performing diagnosis itself. Its intended use is for "review and analysis by trained medical practitioners," which implies the images are for the practitioner's diagnostic work, not for the device to diagnose.

No

The device description explicitly states it consists of a "state-of-the-art LCD monitor and a high-resolution graphic control board," which are hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "displaying and viewing digital medical images for review and analysis by trained medical practitioners." This describes a device used for visualizing medical images, not for performing tests on biological samples (in vitro).
  • Device Description: The description focuses on the hardware (LCD monitor, graphic control board) and its function in displaying images from a PACS workstation. There is no mention of reagents, assays, or analysis of biological specimens.
  • Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
    • Analysis of biological samples (blood, urine, tissue, etc.)
    • Detection or measurement of specific analytes
    • Diagnosis based on laboratory test results

The device is clearly intended for the display and review of medical images, which falls under the category of medical imaging devices, not in vitro diagnostics.

N/A

Intended Use / Indications for Use

The CX20N(CX20PUX) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners.

Product codes

PGY

Device Description

CX20N(CX20PUX) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for color image display. The WIDE controller board is installed into the PACS workstation computer system to display PACS medical images.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Trained medical practitioners

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

The tests conducted for resolution, luminance, contrast and noise all met the acceptance criteria specified in the standards.

Key Metrics

Not Found

Predicate Device(s)

K032960

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 7, 2016

WIDE Corporation % Mr. YeoJin Yun RA Manager 12 Wongomae-Ro, Giheung-Gu Yongin-Si, Gyeonggi-Do 17086 REPUBLIC OF KOREA

Re: K160355 Trade/Device Name: CX20N(CX20PUX) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: PGY Dated: February 5, 2016 Received: February 8, 2016

Dear Mr. Yun:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

1

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Robert Ochs

Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K160355

Device Name CX20N(CX20PUX)

Indications for Use (Describe)

The CX20N(CX20PUX) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

[As required by 21 CFR 807.92]

This 510(k) summary of safety and effectiveness information is prepared in accordance with 21 CFR 807.92

1. Date Prepared [21 CFR 807.92(a) (1)]

02/05/2016

2. Submitter's Information [21 CFR 807.92(a) (1)]

Name of Sponsor:WIDE Corporation.
Address:12 Wongomae-Ro, Giheung-Gu, Yongin-Si, Gyeonggi-Do
17086, Republic of Korea
Contact Name:YeoJin Yun
Telephone #:+82-31-218-1675
Fax #:+82-31-218-7400
Email:yyjin@widecorp.com
Registration Number:3004082357
Name of Manufacturer:Same as Sponsor

3. Trade Name, Common Name, Classification [21 CFR 807.92(a) (2)]

Model Name:CX20N(CX20PUX)
Common Name:TFT LCD Medical Monitor System
Classification Name:Display, Diagnostic Radiology
Regulation Number:21 CFR 892.2050
Product Code:PGY
Device Class:2
Review Panel:Radiology

4. Identification of Predicate Device(s) [21 CFR 807.92(a) (3)]

510(k) Number:K032960
Applicant:WIDE Corporation.
Model Name:The WIDE 2MP TFT LCD Monitor System
Common Name:TFT LCD Medical Monitor System
Classification Name:System, Image Processing, Radiological
Regulation Number:21 CFR 892.2050
Product Code:LLZ
Device Class:2

4

5. Description of the Device [21 CFR 807.92(a) (4)]

CX20N(CX20PUX) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for color image display. The WIDE controller board is installed into the PACS workstation computer system to display PACS medical images.

6. Intended Use [21 CFR 807.92(a) (5)]

CX20N(CX20PUX) is intended to be used to display and view digital medical images for review and analysis by trained medical practitioners.

7. Technological Characteristics [21 CFR 807.92(a) (6)]

The device is an image display system which consists of computer software and components. The device does not contact the patient, nor does it control any life sustaining devices. A physician or trained medical practitioner provides ample opportunity for competent human intervention to interpret images and information being displayed.

ParameterSubject DevicePredicate Device
510(k) NumberUnknownK032960
Model NameCX20N(CX20PUX)The WIDE 2MP TFT LCD
Monitor System
ManufacturerWIDE Corporation.
Common NameTFT LCD Medical Monitor System
Classification NameDisplay, Diagnostic RadiologySystem, Image Processing,
Radiological
Classification PanelRadiology
Classification Regulation21 CFR 892.2050
Product CodePGYLLZ
Device ClassClass II
Intended UseCX20N(CX20PUX) is intended
to be used in displaying and
viewing digital medical images
for review and analysis by trained
medical practitioners.The WIDE 2MP TFT LCD
Monitor System If 7902A
displaying and viewing digital
medical images for review and
analysis by trained medical
practitioners.
LCD Panel Size21.3"21.3"

8. Substantial Equivalence [21 CFR 807.92(b) (1) and 807.92]

5

ParameterSubject DevicePredicate Device
Resolution1600×12001600×1200
Pixel pitch0.270mm x 0.270mm0.270mm x 0.270mm
Brightness800cd/m²770cd/m²
Contrast Ratio1400 : 11100:1
Input SignalDVI-I, DisplayPortDVI-I
Power Supply100~240 VAC, 50/60Hz100~240 VAC, 50/60Hz
Color/MonochromeColorColor

When compared to the predicate devices (K032960), the CX20N(CX20PUX) presented in this submission has the same of the followings:

  • Intended Use
  • Technological characteristics
  • LCD Panel Size
  • Resolution
  • Pixel pitch

The two devices share the similar performance as the following:

  • Brightness
  • Contrast Ratio

9. Summary of Non-Clinical Data

CX20N(CX20PUX) comply with the following international and FDA-recognized consensus standards:

| IEC 60601-1: | Medical Electrical Equipment -- Part 1: General
Requirements For Basic Safety And Essential Performance |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IEC 60601-1-2: | Medical Electrical Equipment - Part 1-2: General
Requirements For Basic Safety And Essential Performance -
Collateral Standard: Electromagnetic Compatibility -
Requirements And Tests |

The tests conducted for resolution, luminance, contrast and noise all met the acceptance criteria specified in the standards.

10. Summary of Clinical Data

No clinical studies were considered necessary and performed.

6

11. Conclusion [21 CFR 807.92(b) (3)]

Subject Device is substantially equivalent to the currently marketed and predicate devices in terms of design features, fundamental scientific technology, indications for use, and safety and effectiveness.

Additionally, the safety of the subject device was validated through tests including IEC60601-1 and IEC 60601-1-2. The effectiveness of the device was validated through tests for resolution, luminance, contrast and noise.

The results of these tests demonstrate that CX20N(CX20PUX) meets the acceptance criteria and is adequate for this intended use. The comparison of technological characteristics, non-clinical performance data, safety testing demonstrates that the device is as safe and effective as the predicate device and performs as well as the predicate device.